ETIDIOH - NEW

  {Summary} Time Period: August 31, 2025 - September 06, 2025 -- H5 Detection :  4 sites ( 0.9% ) -- No Detection :  418 sites ( 99.1% ) -- No samples in last week :  43 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

{Summary} Time Period: August 24, 2025 - August 30, 2025 -- H5 Detection :  3 sites ( 0.7% ) -- No Detection :  428 sites ( 99.3% ) -- No samples in last week :  31 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  Summary -- What is already known about this topic? - As of January 1, 2025, 37 human cases of highly pathogenic avian influenza (HPAI) A( H5N1 ) had been detected in California , none of which occurred in San Francisco. -- What is added by this report? - On January 9, 2025, a case of HPAI A(H5N1) infection was identified in a school-aged child in San Francisco through enhanced surveillance (influenza A virus subtyping of a sample of specimens weekly). No source of exposure was identified, and investigations found no laboratory evidence of human-to-human transmission among close contacts. -- What are the implications for public health practice? - Enhanced surveillance and timely subtyping of a subset of influenza A–positive specimens, including specimens from persons without known A(H5N1) exposure, are important to detect avian influenza A virus infections. Public health investigations are critical to monitoring for human-to-human transmission. Abstract In response to a highly pat...

  {Summary} Time Period: August 17, 2025 - August 23, 2025 -- H5 Detection :  2 sites ( 0.5% ) -- No Detection :  429 sites ( 99.5% ) -- No samples in last week :  31 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Summary} Time Period: August 10, 2025 - August 16, 2025 -- H5 Detection :  1 site ( 0.2% ) -- No Detection :  422 sites ( 99.8% ) -- No samples in last week :  37 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Summary} Time Period: August 03, 2025 - August 09, 2025 -- H5 Detection :  2 sites ( 0.5% ) -- No Detection :  425 sites ( 99.5% ) -- No samples in last week :  33 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Summary} Time Period: July 27, 2025 - August 02, 2025 -- H5 Detection :  4 sites ( 0.9% ) -- No Detection :  430 sites (99.1%) -- No samples in last week :  24 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Excerpt} Time Period: July 20, 2025 - July 26, 2025 -- H5 Detection :  4 sites ( 1.0% ) -- No Detection :  391 sites ( 99.0% ) -- No samples in last week :  38 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Excerpt} Time Period: July 13, 2025 - July 19, 2025 -- H5 Detection :  2 sites ( 0.5% ) -- No Detection :  380 sites ( 99.5% ) -- No samples in last week :  47 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Excerpt} Time Period: July 06, 2025 - July 12, 2025 -- H5 Detection :  2 sites ( 0.5% ) -- No Detection :  395 sites ( 99.5% ) -- No samples in last week :  51 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html _____

  {Excerpt} Time Period: June 29, 2025 - July 05, 2025 -- H5 Detection :  2 sites ( 0.6% ) -- No Detection :  330 sites ( 99.4% ) -- No samples in last week :  77 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Excerpt} Time Period: June 22, 2025 - June 28, 2025 -- H5 Detection :  3 sites ( 0.8% ) -- No Detection :  370 sites ( 99.2% ) -- No samples in last week :  52 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

Summary -- What is already known about this topic? - Parvovirus B19 (B19) is a respiratory virus that can cause adverse fetal outcomes in pregnant women and persons who are immunocompromised or have chronic hemolytic blood disorders . After relatively low rates during the COVID-19 pandemic years of 2021–2023, B19 activity in 2024 exceeded that of prepandemic years. -- What is added by this report? - Data from the National Syndromic Surveillance Program indicated that the proportion of sera specimens positive for B19 antibodies during January–May 10, 2025, was higher than during the same period in 2024 , suggesting a sustained increase in B19 transmission. -- What are the implications for public health practice? - Health care providers should have a heightened suspicion of and consider providing testing for B19 infection among groups at high risk for severe outcomes, including pregnant women with compatible symptoms or exposure to B19. Among pregnant women, health care providers should ...

  {Excerpts} Time Period: June 15, 2025 - June 21, 2025 - H5 Detection :  3 sites ( 0.8% ) - No Detection :  367 sites ( 99.2% ) - No samples in last week :  55 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/bird-flu/h5-monitoring/index.html ____

Summary - What is already known about this topic? -- Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP) in school-aged children . In the United States, M. pneumoniae infection prevalence decreased during the COVID-19 pandemic and remained low through 2023. - What is added by this report? -- The number of hospital discharges of children with M. pneumoniae –associated CAP from U.S. pediatric hospitals increased sharply in 2024, accounting for approximately one half of hospitalized children with CAP. This number included children aged <5 years , a group in which M. pneumoniae infections have historically been less commonly reported. Data on length of hospitalization and intensive care unit admissions indicate that M. pneumoniae infections in 2024 were not more severe than 2018–2023 infections. - What are the implications for public health practice? -- Increased awareness among health care providers might improve diagnosis and could guide treatment of M. pneum...

  {Excerpt} Time Period: June 01, 2025 - June 07, 2025 - H5 Detection :  4 sites ( 1.1% ) - No Detection :  370 sites ( 98.9% ) - No samples in last week :  73 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/bird-flu/h5-monitoring/index.html ____

  {Excerpt} Time Period: June 01, 2025 - June 07, 2025 - H5 Detection :  4 sites ( 1.1% ) - No Detection :  370 sites ( 98.9% ) - No samples in last week :  73 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/bird-flu/h5-monitoring/index.html ____

  {Excerpt} Time Period: May 25, 2025 - May 31, 2025 - H5 Detection :  10 sites ( 2.5% ) - No Detection :  389 sites ( 97.5% ) - No samples in last week :  52 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/nwss/rv/wwd-h5.html ____

  {Excerpt} Time Period: May 18, 2025 - May 24, 2025 -- H5 Detection :  17 sites ( 5.0% ) - No Detection :  322 sites ( 95.0% ) - No samples in last week :  116 sites (...) Source: US Centers for Disease Control and Prevention,  https://www.cdc.gov/bird-flu/h5-monitoring/index.html ____

  Summary -- What is already known about this topic? - Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is a zoonotic virus transmitted sporadically from camels to humans , with limited subsequent human-to-human transmission . Most reported human cases of MERS have occurred in or near the Arabian Peninsula . Standardized clinical and epidemiologic criteria are used to determine who in the United States should be tested for MERS-CoV. In the United States , the last identified and confirmed MERS cases occurred in 2014 . -- What is added by this report? - Global reported MERS cases have declined substantially since the COVID-19 pandemic. Numbers of travelers entering the United States from in or near the Arabian Peninsula declined during the COVID-19 pandemic, but now have returned to prepandemic levels. U.S. MERS-CoV testing declined during 2017–2023 and remains low relative to prepandemic years. Clinical and epidemiologic criteria to guide U.S. testing were updated in ...